Rates, distribution and implications of postzygotic mosaic mutations in autism spectrum disorder

Nature Neuroscience

Volumn 20, Issue 9, 2017, Pages 1217-1224

  Lim, Elaine T ^a,b,c,d   Uddin, Mohammed ^e   De Rubeis, Silvia ^f   Chan, Yingleong ^c,d   Kamumbu, Anne S ^a,b,c   Zhang, Xiaochang ^a,b,c   D'Gama, Alissa M ^a,b,c   Kim, Sonia N ^a,b,c   Hill, Robert Sean ^a,b,c   Goldberg, Arthur P ^f   Poultney, Christopher ^f   Minshew, Nancy J ^g   Kushima, Itaru ^h   Aleksic, Branko ^h   Ozaki, Norio ⁱ   Parellada, Mara ⁱ   Arango, Celso ^i,p   Penzol, Maria J ^j,k,l   Carracedo, Angel ^f   Kolevzon, Alexander ^f   Hultman, Christina M ^m   Weiss, Lauren A ⁿ   Fromer, Menachem ^f   Chiocchetti, Andreas G ^o   Freitag, Christine M ^o   Church, George M ^c,d   Scherer, Stephen W ^f,q,r,s   Buxbaum, Joseph D ^f   Walsh, Christopher A ^a,b,c   more..

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD UNIVERSITY   (United States)

^e Dubai Healthcare City   (United Arab Emirates)

^f MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^g UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^h NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

ⁱ HOSPITAL GENERAL UNIVERSITARIO GREGORIO MARAÑÓN   (Spain)

^j UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

^k CENTRO DE INVESTIGACIÓN BIOMÉDICA EN RED DE ENFERMEDADES RARAS CIBERER   (Spain)

^l KING ABDULAZIZ UNIVERSITY   (Saudi Arabia)

^m KAROLINSKA INSTITUTE   (Sweden)

ⁿ UNIVERSITY OF CALIFORNIA   (United States)

^o UNIVERSITY HOSPITAL FRANKFURT   (Germany)

^p HOSPITAL FOR SICK CHILDREN   (Canada)

^q HOSPITAL FOR SICK CHILDREN   (Canada)

^r UNIVERSITY OF TORONTO   (Canada)

^s UNIVERSITY OF TORONTO   (Canada)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMYGDALA; ANTISENSE VECTOR; ARTICLE; AUTISM; CORRELATION COEFFICIENT; EXCISION REPAIR; EXOME; EXON; GENE; GENE EXPRESSION; GENE MUTATION; GENE SEQUENCE; GENETIC ASSOCIATION; HNRNPU GENE; HUMAN; MOSAICISM; PRIORITY JOURNAL; SCN2A GENE; SMARCA4 GENE; SOMATIC MUTATION; GENETIC DATABASE; GENETIC PREDISPOSITION; GENETIC VARIATION; GENETICS; MISSENSE MUTATION; PHYSIOLOGY; TRENDS; ZYGOTE;

AUTISM SPECTRUM DISORDER; DATABASES, GENETIC; GENETIC PREDISPOSITION TO DISEASE; GENETIC VARIATION; HUMANS; MOSAICISM; MUTATION, MISSENSE; ZYGOTE;

EID: 85028454831     PISSN: 10976256     EISSN: 15461726     Source Type: Journal    
DOI: 10.1038/nn.4598     Document Type: Article

References (50)

1. Gaugler, T. et al. Most genetic risk for autism resides with common variation. Nat. Genet. 46, 881-885 (2014).
2. Sanders, S.J. et al. Insights into autism spectrum disorder genomic architecture and biology from 71 risk loci. Neuron 87, 1215-1233 (2015).
3. Pinto, D. et al. Convergence of genes and cellular pathways dysregulated in autism spectrum disorders. Am. J. Hum. Genet. 94, 677-694 (2014).
4. De Rubeis, S. et al. Synaptic, transcriptional and chromatin genes disrupted in autism. Nature 515, 209-215 (2014).
5. Iossifov, I. et al. The contribution of de novo coding mutations to autism spectrum disorder. Nature 515, 216-221 (2014).
6. Yu, T.W. et al. Using whole-exome sequencing to identify inherited causes of autism. Neuron 77, 259-273 (2013).
7. Lim, E.T. et al. Rare complete knockouts in humans: Population distribution and significant role in autism spectrum disorders. Neuron 77, 235-242 (2013).
8. Jamuar, S.S. et al. Somatic mutations in cerebral cortical malformations. N. Engl. J. Med. 371, 733-743 (2014).
9. Poduri, A., Evrony, G.D., Cai, X. & Walsh, C.A. Somatic mutation, genomic variation, and neurological disease. Science 341, 1237758 (2013).
10. Genovese, G. et al. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence. N. Engl. J. Med. 371, 2477-2487 (2014).
11. Pleasance, E.D. et al. A comprehensive catalogue of somatic mutations from a human cancer genome. Nature 463, 191-196 (2010).
12. Polak, P. et al. Cell-of-origin chromatin organization shapes the mutational landscape of cancer. Nature 518, 360-364 (2015).
13. Prendergast, J.G. & Semple, C.A. Widespread signatures of recent selection linked to nucleosome positioning in the human lineage. Genome Res. 21, 1777-1787 (2011).
14. Cotney, J. et al. The autism-associated chromatin modifier CHD8 regulates other autism risk genes during human neurodevelopment. Nat. Commun. 6, 6404 (2015).
15. Koren, A. et al. Differential relationship of DNA replication timing to different forms of human mutation and variation. Am. J. Hum. Genet. 91, 1033-1040 (2012).
16. Woo, Y.H. & Li, W.H. DNA replication timing and selection shape the landscape of nucleotide variation in cancer genomes. Nat. Commun. 3, 1004 (2012).
17. Adzhubei, I., Jordan, D.M. & Sunyaev, S.R. Predicting functional effect of human missense mutations using PolyPhen-2. Current Protocols in Human Genetics (eds.Haines, J.L. et al.,) Chapter 7, Unit 7.20 (Wiley, 2013).
18. Kumar, P., Henikoff, S. & Ng, P.C. Predicting the effects of coding non-synonymous variants on protein function using the SIFT algorithm. Nat. Protoc. 4, 1073-1081 (2009).
19. Kircher, M. et al. A general framework for estimating the relative pathogenicity of human genetic variants. Nat. Genet. 46, 310-315 (2014).
20. Uddin, M. et al. Brain-expressed exons under purifying selection are enriched for de novo mutations in autism spectrum disorder. Nat. Genet. 46, 742-747 (2014).
21. Carvill, G.L. et al. Targeted resequencing in epileptic encephalopathies identifies de novo mutations in CHD2 and SYNGAP1. Nat. Genet. 45, 825-830 (2013).
22. Petrovski, S., Wang, Q., Heinzen, E.L., Allen, A.S. & Goldstein, D.B. Genic intolerance to functional variation and the interpretation of personal genomes. PLoS Genet. 9, e1003709 (2013).
23. Jelinic, P. et al. Recurrent SMARCA4 mutations in small cell carcinoma of the ovary. Nat. Genet. 46, 424-426 (2014).
24. Kosho, T., Okamoto, N. & Coffin-Siris Syndrome International Collaborators Genotype-phenotype correlation of Coffin-Siris syndrome caused by mutations in SMARCB1, SMARCA4, SMARCE1, and ARID1A. Am. J. Med. Genet. C. Semin. Med. Genet. 166C, 262-275 (2014).
25. Forbes, S.A. et al. COSMIC: Exploring the world's knowledge of somatic mutations in human cancer. Nucleic Acids Res. 43, D805-D811 (2015).
26. Pugh, T.J. et al. Medulloblastoma exome sequencing uncovers subtype-specific somatic mutations. Nature 488, 106-110 (2012).
27. Qiu, Z. & Ghosh, A. A calcium-dependent switch in a CREST-BRG1 complex regulates activity-dependent gene expression. Neuron 60, 775-787 (2008).
28. Acuna-Hidalgo, R. et al. Post-zygotic point mutations are an underrecognized source of de novo genomic variation. Am. J. Hum. Genet. 97, 67-74 (2015).
29. Freed, D. & Pevsner, J. The contribution of mosaic variants to autism spectrum disorder. PLoS Genet. 12, e1006245 (2016).
30. Morris, J.S., Ohman, A. & Dolan, R.J. Conscious and unconscious emotional learning in the human amygdala. Nature 393, 467-470 (1998).
31. Adolphs, R., Tranel, D. & Damasio, A.R. The human amygdala in social judgment. Nature 393, 470-474 (1998).
32. Baron-Cohen, S. et al. The amygdala theory of autism. Neurosci. Biobehav. Rev. 24, 355-364 (2000).
33. Rutishauser, U. et al. Single-neuron correlates of atypical face processing in autism. Neuron 80, 887-899 (2013).
34. Xu, X. et al. Modular genetic control of sexually dimorphic behaviors. Cell 148, 596-607 (2012).
35. Gkogkas, C.G. et al. Autism-related deficits via dysregulated eIF4E-dependent translational control. Nature 493, 371-377 (2013).
36. Campbell, I.M. et al. Parental somatic mosaicism is underrecognized and influences recurrence risk of genomic disorders. Am. J. Hum. Genet. 95, 173-182 (2014).
37. O'Roak, B.J. et al. Recurrent de novo mutations implicate novel genes underlying simplex autism risk. Nat. Commun. 5, 5595 (2014).
38. Lindhurst, M.J. et al. A mosaic activating mutation in AKT1 associated with the Proteus syndrome. N. Engl. J. Med. 365, 611-619 (2011).
39. Weiss, L.A. et al. Association between microdeletion and microduplication at 16p11.2 and autism. N. Engl. J. Med. 358, 667-675 (2008).
40. Sebat, J. et al. Strong association of de novo copy number mutations with autism. Science 316, 445-449 (2007).
41. DePristo, M.A. et al. A framework for variation discovery and genotyping using next-generation DNA sequencing data. Nat. Genet. 43, 491-498 (2011).
42. Cingolani, P. et al. A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3. Fly (Austin) 6, 80-92 (2012).
43. Abecasis, G.R. et al. Genomes Project. A map of human genome variation from population-scale sequencing. Nature 467, 1061-1073 (2010).
44. Kang, H.J. et al. Spatio-temporal transcriptome of the human brain. Nature 478, 483-489 (2011).
45. Darnell, J.C. et al. FMRP stalls ribosomal translocation on mRNAs linked to synaptic function and autism. Cell 146, 247-261 (2011).
46. Iossifov, I. et al. De novo gene disruptions in children on the autistic spectrum. Neuron 74, 285-299 (2012).
47. Fromer, M. et al. De novo mutations in schizophrenia implicate synaptic networks. Nature 506, 179-184 (2014).
48. Ramos, P. et al. Small cell carcinoma of the ovary, hypercalcemic type, displays frequent inactivating germline and somatic mutations in SMARCA4. Nat. Genet. 46, 427-429 (2014).
49. Le Loarer, F. et al. SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas. Nat. Genet. 47, 1200-1205 (2015).
50. Tsurusaki, Y. et al. Mutations affecting components of the SWI/SNF complex cause Coffin-Siris syndrome. Nat. Genet. 44, 376-378 (2012).